FdaApplication
NDA 215040
Identifiers
- fda_app_no: NDA215040
Properties
| Property | Value |
|---|---|
| applicant_name | GALEPHAR PHARMACEUTICAL RESEARCH INC |
| application_type | NDA |
| approval_date | 2024-02-13 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEGUBETI | ACETYLCYSTEINE LYSINE | EQ 2.5GM BASE/PACKET | FOR SOLUTION;ORAL |
| LEGUBETI | ACETYLCYSTEINE LYSINE | EQ 500MG BASE/PACKET | FOR SOLUTION;ORAL |
2 products